BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25010865)

  • 1. Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Br J Cancer; 2014 Sep; 111(7):1421-31. PubMed ID: 25010865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
    Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
    Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.
    Veitonmäki T; Murtola TJ; Talala K; Taari K; Tammela T; Auvinen A
    PLoS One; 2016; 11(4):e0153413. PubMed ID: 27100876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.
    Veitonmäki T; Murtola TJ; Määttänen L; Taari K; Stenman UH; Tammela TL; Auvinen A
    Prostate; 2015 Sep; 75(13):1394-402. PubMed ID: 26073992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Schenk JM; Calip GS; Tangen CM; Goodman P; Parsons JK; Thompson IM; Kristal AR
    Am J Epidemiol; 2012 Jul; 176(2):156-63. PubMed ID: 22759721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
    Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
    Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
    Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
    Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Nygård LH; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
    Prostate; 2017 Jun; 77(9):1029-1035. PubMed ID: 28480542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
    Sarre S; Määttänen L; Tammela TL; Auvinen A; Murtola TJ
    Scand J Urol; 2016 Aug; 50(4):267-73. PubMed ID: 26927237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study.
    Skriver C; Dehlendorff C; Borre M; Brasso K; Larsen SB; Tjønneland A; Pottegård A; Hallas J; Sørensen HT; Friis S
    Cancer Causes Control; 2020 Feb; 31(2):139-151. PubMed ID: 31823168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
    Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
    Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).
    Murad AS; Down L; Davey Smith G; Donovan JL; Athene Lane J; Hamdy FC; Neal DE; Martin RM
    Int J Cancer; 2011 Mar; 128(6):1442-8. PubMed ID: 20506261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
    Kaapu KJ; Murtola TJ; Määttänen L; Talala K; Taari K; Tammela TL; Auvinen A
    Cancer Causes Control; 2016 Feb; 27(2):157-64. PubMed ID: 26573846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
    Bhindi B; Margel D; Hamilton RJ; Fernandes KA; Trottier G; Hersey KM; Finelli A; Trachtenberg J; Zlotta A; Kulkarni GS; Toi A; Evans A; van der Kwast TH; Fleshner NE
    Urology; 2014 Nov; 84(5):1073-80. PubMed ID: 25443907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.
    García Rodríguez LA; González-Pérez A
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):649-53. PubMed ID: 15066932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number of Screening Rounds and Postscreening Prostate Cancer Incidence: Results from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer Study.
    Pakarainen T; Raitanen J; Talala K; Taari K; Kujala P; Tammela TL; Auvinen A
    Eur Urol; 2016 Sep; 70(3):499-505. PubMed ID: 27210461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer.
    Roberts RO; Jacobson DJ; Girman CJ; Rhodes T; Lieber MM; Jacobsen SJ
    Mayo Clin Proc; 2002 Mar; 77(3):219-25. PubMed ID: 11888024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.